Showing results (181-190 of 313) with videos related to

Sort By:
Pageof 32
Diabetes|September 15, 2018
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose ToleranceChris Shannon, Aurora Merovci, Juan Xiong, et al.
Bioscience Reports|October 12, 2012
TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cellsSophie E Hussey, Hanyu Liang, Sheila R Costford, et al.
Obesity Surgery|September 30, 2008
Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric bandingAmalia Gastaldelli, Lucia Perego, Michele Paganelli, et al.
Frontiers in Physiology|December 20, 2021
The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in HumansJuan P Palavicini, Alberto Chavez-Velazquez, Marcel Fourcaudot, et al.
BMJ Open Diabetes Research & Care|October 18, 2024
Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjectsAurora Merovci, Brittany Finley, Andrea Hansis-Diarte, et al.
Diabetes Care|January 31, 2024
Empagliflozin Reduces Liver Fat in Individuals With and Without DiabetesSiham Abdelgani, Ahmed Khattab, John Adams, et al.
Diabetes Care|May 30, 2009
The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin aloneRalph A DeFronzo, Miguel N Hissa, Alan J Garber, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2018
Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes MellitusHussein Al Jobori, Giuseppe Daniele, John Adams, et al.
Diabetes Care|August 27, 2016
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 DiabetesGiuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, et al.
Diabetes Care|July 27, 2011
Two-step approach for the prediction of future type 2 diabetes riskMuhammad A Abdul-Ghani, Tamam Abdul-Ghani, Michael P Stern, et al.
Pageof 32